Module 1-Introduction To Health Technology Assessment
Module 1-Introduction To Health Technology Assessment
• RA 10606: National Health Insurance Act of 2013 mandated the utilization of HTA in guiding
PhilHealth’s coverage of health services (Congress of the Philippines, 2013).
• AO 2016 - 0034: The New Implementing Guidelines of the Philippine National Formulary System
(PNFS) required that any medicine considered for inclusion in the PNF shall be assessed its benefit-
risk assessment (safety and efficacy), cost27 effectiveness, affordability and public health relevance.
(Department of Health, 2016).
• AO 2018-0026: Framework for the Use of HTA to Guide Coverage Decisions in Support of UHC
provided an explicit framework for a systematic and consistent use of HTA to guide health coverage
decisions of both the DOH and PhilHealth (Department of Health, 2018).
• RA 11223: Universal Healthcare Act institutionalized HTA as a fair and transparent priority-setting
mechanism that shall be recommendatory to the DOH and PhilHealth for the development of policies,
programs, regulations, and the determination of a range of entitlements such as drugs, medicines,
pharmaceutical products, other devices, procedures, and services (Congress of the Philippines, 2019).
• To provide clear guidelines to researchers on methodological standards in evaluating the clinical and
economic value of health technologies as well as other relevant aspects on the adoption of health
technologies including sources of data in conducting assessments
• To ensure the consistency of methods and reporting standards of researchers so that HTA reports
meet the needs of the HTA Council and healthcare decision-makers for timely, comprehensive, reliable,
relevant, rigorous, and accurate evidence on health technologies.
• To give guidance to healthcare professionals, patients, and the general public on the decision
framework of the HTAC and healthcare decision-makers.
What is the scope of this document?
HTA aims to produce recommendations for healthcare decision-makers on the use of the following health
technologies:
• Medicines
• Vaccines
• Medical devices
• Medical and surgical procedures
• Screening procedures and diagnostics
• Promotive and preventive health interventions
• Traditional and complementary medicine
• Other health interventions and technologies such as systems, organizations, and delivery systems of
care
This document, however, only applies to pharmaceutical products to be listed in the PNF, different health
technologies and services delivered by DOH public health programs, vaccines covered under the National
Immunization Program, and the benefits packages developed and covered by PhilHealth.